Gastroenterology General Medicine Strong — standard outcome measure in UC clinical trials; endorsed by BSG/ECCO
Mayo Score for Ulcerative Colitis Activity
Assesses ulcerative colitis (UC) disease activity using clinical and endoscopic findings. Guides treatment decisions including steroid use and biologics.
References
- Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med. 1987;317(26):1625–1629.
- NICE NG130. Ulcerative colitis: management. 2019.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Crohn's Disease Activity Index (CDAI) · Inflammatory Bowel Disease
- Truelove and Witts Severity Index for Ulcerative Colitis · Inflammatory Bowel Disease
- Ulcerative Colitis Endoscopic Index of Severity (UCEIS) · Inflammatory Bowel Disease
- Simplified Endoscopic Score for Crohn's Disease (SES-CD) · Inflammatory Bowel Disease
- Travis Criteria for Severe Ulcerative Colitis · Inflammatory Bowel Disease
Drugs
- Prednisolone (Rheumatology) · Corticosteroid (oral) — bridge/anti-inflammatory
- Pindolol · Non-selective β-blocker (with intrinsic sympathomimetic activity)
- Dapsone · Anti-inflammatory / Antimicrobial
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
- Prednisolone (Systemic) · Systemic Corticosteroid — Acute Dermatoses
Pathways
- Upper GI Bleeding · BSG Guidelines 2019; NICE NG141
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.